1373425-27-4

Basic information

• Product Name: C₂₂H₁₄Cl₂N₂O
• Synonyms: C₂₂H₁₄Cl₂N₂O
• CAS NO: 1373425-27-4
• Molecular Weight: 393.272
• Mol File: 1373425-27-4.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: C₂₂H₁₄Cl₂N₂O(CAS DataBase Reference)
• NIST Chemistry Reference: C₂₂H₁₄Cl₂N₂O(1373425-27-4)
• EPA Substance Registry System: C₂₂H₁₄Cl₂N₂O(1373425-27-4)

Safety Data

• Hazardous Substances Data: 1373425-27-4(Hazardous Substances Data)

Upstream product

• 17630-76-1 5-chloroindole 2,3-dione 
• 65798-06-3 N-(4-chlorophenyl)-2-(hydroxyimino)ethanamide 
• 106-47-8 4-chloro-aniline 
• 174636-77-2 6-chloro-2-phenyl-quinoline-4-carbonyl chloride 
• 6633-62-1 6-chloro-2-phenylquinoline-4-carboxylic acid 

Relevant articles and documents

Design, synthesis and evaluation of quinoline-based small molecule inhibitor of stat3

As STAT3 has been validated as an anticancer target, its inhibitors have been shown to possess therapeutic promise for the treatment of human cancers. To identify novel and selective STAT3 inhibitors, a virtual screening based on the STAT3 SH2 domain was performed and a small molecule, 2-phenylquinoline-4- carboxylic acid (5a), with an inhibition constant Ki value of 17.53 iM to STAT3 was discovered. On this basis, the derivatives of 5a including esters, amides and dimers were synthesized. The bioactivity and inhibitory selectivity of the derivatives were assayed using human breast cancer cell lines, MDA-MB-468 and MCF-7. Among the derivatives, 5c and 9b showed the most potent inhibitory activity with a good selectivity, and also inhibited STAT3 protein level of MDA-MB-468 cells. The results demonstrated a successful application of virtual screening for lead discovery. Compound 9b might be an effective STAT3 inhibitor lead for the further development of antitumor agents.